Alfa-1-antitrypsin deficiency: a predisposing factor leading to invasive infections?


Journal

Infectious diseases (London, England)
ISSN: 2374-4243
Titre abrégé: Infect Dis (Lond)
Pays: England
ID NLM: 101650235

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 22 11 2019
medline: 2 6 2020
entrez: 22 11 2019
Statut: ppublish

Résumé

This case report highlights for the first time a possible link between the presence of alfa-1-antitrypsin deficiency (AATD) and the susceptibility to invasive infections. The current patient, with known AATD, initially presented with nausea, vomiting and headache secondary to Listeria monocytogenes rhombencephalitis. Further on, he developed respiratory insufficiency due to probable invasive pulmonary aspergillosis. Diagnostic work-up could not show any arguments for an underlying immunodeficiency or malignancy. The consecutive course of two rare invasive infections in a healthy individual posed the hypothesis if the underlying AATD could be considered a possible trigger for infections. Indirect clinical observations in literature indeed support this link and in addition, two possible pathophysiological pathways might explain the higher susceptibility for infections in AATD patients. First, alveolar macrophages are dysfunctional in AATD patients leading to a lower apoptotic clearance of bacteria and other (mostly intracellular) pathogens. Secondly, a lower release and lower function of tumour necrosis factor α (TNFα) is seen in alfa-1-antitrypsin depletion, priming the path to more frequent infections, a mechanism that is similar in anti-TNFα treated patients. This case is the first to report on severe or invasive infections related to AATD in humans.

Identifiants

pubmed: 31749396
doi: 10.1080/23744235.2019.1690163
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-134

Auteurs

Sanne De Smet (S)

Department of Internal Medicine, Maria Middelares Hospital, Ghent, Belgium.

Jan Dierick (J)

Department of Microbiology, Maria Middelares Hospital, Ghent, Belgium.

Sophia Steyaert (S)

Department of Microbiology, Maria Middelares Hospital, Ghent, Belgium.

Marie Schurgers (M)

Department of Intensive Care Medicine, Maria Middelares Hospital, Ghent, Belgium.

Christophe Van Steenkiste (C)

Department of Gastroenterology and Hepatology, Maria Middelares Hospital, Ghent, Belgium.
Department of Gastroenterology and Hepatology, Belgium - University Antwerp, Wilrijk, Belgium.

Sarah Loof (S)

Department of Pneumology, Maria Middelares Hospital, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH